Cipla gets tentative US nod for HIV tablets

Drugmaker Cipla has received a tentative US Food and Drug Administration approval for its HIV treatment tablets, which have a combination of lamivudine, nevirapine and zidovudine drugs, the drug regulator's website showed.

Cipla sells the combination drug under the brand name 'Duovir N' outside the United States.

The company plans to use a different brand name in the US for this drug, S. Radhakrishnan, a director on Cipla board told Reuters.

Copyright: Thomson Reuters